{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:43:24Z","timestamp":1760982204980},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.neulet.2007.06.028","type":"journal-article","created":{"date-parts":[[2007,6,23]],"date-time":"2007-06-23T11:08:37Z","timestamp":1182596917000},"page":"228-231","source":"Crossref","is-referenced-by-count":27,"title":["Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes"],"prefix":"10.1016","volume":"422","author":[{"given":"Lorenzo","family":"Kiferle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ceravolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Petrozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Frosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubaldo","family":"Bonuccelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Murri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2007.06.028_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.56.5.595","article-title":"Prevalence and clinical correlates of psychotic symptoms in Parkinson disease","volume":"56","author":"Aarsland","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2007.06.028_bib2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/1531-8249(200012)48:6<868::AID-ANA7>3.0.CO;2-0","article-title":"Delusions associated with elevated muscarinic binding in dementia with Lewy bodies","volume":"48","author":"Ballard","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2007.06.028_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S0004-282X2007000100004","article-title":"Association analysis between the C516T polymorphism in the 5-HT2A receptor gene and schizophrenia","volume":"65","author":"Bertola","year":"2007","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neulet.2007.06.028_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1185\/030079902125000813","article-title":"Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series","volume":"18","author":"Bullock","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neulet.2007.06.028_bib5","first-page":"434","article-title":"A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders","volume":"1","author":"Collier","year":"1996","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neulet.2007.06.028_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2005.11.005","article-title":"Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease","volume":"12","author":"Burn","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2007.06.028_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(05)64135-9","article-title":"Association between 5HT2A gene promoter polymorphism and anorexia nervosa","volume":"350","author":"Collier","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2007.06.028_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.410220207","article-title":"Aminergic system in Alzheimer's and Parkinson's disease","volume":"22","author":"D\u2019Amato","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2007.06.028_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"Fenelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2007.06.028_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.51.3.811","article-title":"Early dopaminergic drug-induced hallucinations in parkinsonian patients","volume":"51","author":"Goetz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2007.06.028_bib11","first-page":"23","article-title":"5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder","volume":"8","author":"Graf","year":"2006","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.neulet.2007.06.028_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/(SICI)1096-8628(19970725)74:4<370::AID-AJMG6>3.0.CO;2-T","article-title":"No association or linkage between the 5-HT2a\/T102C polymorphism and schizophrenia in Irish families","volume":"74","author":"Hawi","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neulet.2007.06.028_bib13","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/hmg\/7.9.1507","article-title":"5HT-2A and 5HT2c receptor polymorphisms and psychopathology in late onset Alzheimer's disease","author":"Holmes","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2007.06.028_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of the 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2007.06.028_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0893-133X(95)00143-2","article-title":"Intact 5-HT2A receptor exons and the adjoining intron regions in schizophrenia","volume":"14","author":"Ishigaki","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2007.06.028_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01276434","article-title":"Organization of human serotonin transporter gene","volume":"95","author":"Lesch","year":"1994","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neulet.2007.06.028_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00008571-200002000-00006","article-title":"Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease","volume":"10","author":"Makoff","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neulet.2007.06.028_bib18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(96)91650-5","article-title":"5HT 2a receptor T102C polymorphism and schizophrenia","volume":"347","author":"Malhotra","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2007.06.028_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/089198879901200202","article-title":"Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter","volume":"12","author":"Menza","year":"1999","journal-title":"J Geriat. Psychiatry Neurol."},{"key":"10.1016\/j.neulet.2007.06.028_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.mp.4000849","article-title":"Allelic variation of serotonin transporter expression associated with depression in Parkinson's disease","volume":"6","author":"M\u00f6ssner","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2007.06.028_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0304-3940(99)00859-9","article-title":"5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa","volume":"277","author":"Nacmias","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2007.06.028_bib22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(96)90079-3","article-title":"Polymorphism in serotonin transporter gene associated with susceptibility to major depression","volume":"347","author":"Ogilvie","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2007.06.028_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1353-8020(00)00039-0","article-title":"Management of behavioural and psychiatric problems in Parkinson's disease","volume":"7","author":"Rabinstein","year":"2001","journal-title":"Parkinsonism Relat. Dis."},{"key":"10.1016\/j.neulet.2007.06.028_bib24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/mds.1204","article-title":"Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial","volume":"16","author":"Reading","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2007.06.028_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00041444-199800820-00001","article-title":"Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population","volume":"8","author":"Ricketts","year":"1998","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neulet.2007.06.028_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/109065703322783662","article-title":"Serotoninergic polymorphism (5HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease","volume":"7","author":"Rocchi","year":"2003","journal-title":"Genet. Test."},{"key":"10.1016\/j.neulet.2007.06.028_bib27","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0140-6736(05)78745-6","article-title":"5HT2A promoter polymorphism in anorexia nervosa","volume":"351","author":"Sorbi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2007.06.028_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s004060050022","article-title":"Susceptibility for schizophrenia is not influenced by a functional insertion\/deletion variant in the promoter of the serotonin transporter gene","volume":"248","author":"St\u00f6ber","year":"1998","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neulet.2007.06.028_bib29","first-page":"321","article-title":"Association between allele 1 of T102C polymorphism, 5-hydroxitryptamine 2a receptor gene and schizophrenia","volume":"114","author":"Tay","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neulet.2007.06.028_bib30","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/sj.mp.4001105","article-title":"5-HT2A promoter polymorphism \u22121438G\/A in children and adolescents with obsessive-compulsive disorders","volume":"7","author":"Walitza","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2007.06.028_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2003.11.006","article-title":"Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease","volume":"355","author":"Wang","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2007.06.028_bib32","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(96)90939-3","article-title":"Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of schizophrenia (EMASS) Group","volume":"347","author":"Williams","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2007.06.028_bib33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1212\/WNL.45.7.1305","article-title":"Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5HT3 receptor agonist","volume":"45","author":"Zoldan","year":"1995","journal-title":"Neurology"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394007007318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394007007318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T12:57:32Z","timestamp":1546779452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394007007318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0304394007007318"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2007.06.028","relation":{},"ISSN":["0304-3940"],"issn-type":[{"type":"print","value":"0304-3940"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}